Quality of life in patients with psoriasis

Overview of attention for article published in Health and Quality of Life Outcomes, June 2006

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 2,280)
High Attention Score compared to outputs of the same age (99th percentile)

Mentioned by

news: 51 news outlets
twitter: 1 X user

wikipedia: 7 Wikipedia pages

Citations

dimensions_citation: 253 Dimensions

Readers on

mendeley: 335 Mendeley

Summary News X Wikipedia Dimensions citations

So far, Altmetric has seen 65 news stories from 51 outlets.

Almirall: Ilumetri® (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis

Intellasia, 07 Jul 2023

07-Jul-2023 Intellasia | BusinessWire | 8:26 PM At the 25th World Congress of Dermatology Tildrakizumab also significantly…

Almirall: Ilumetri® (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis

Finanzen, 07 Jul 2023

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced that Ilumetri® (tildraki…

Almirall: Ilumetri® (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis

Le Lézard, 07 Jul 2023

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced that Ilumetri® (tildraki…

News story from Finanz Nachrichten on Friday 07 July 2023

Finanz Nachrichten, 07 Jul 2023

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 61 additional news stories.